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Voltage-gated Kv7 potassium channels, encoded by KCNQ genes, have major
physiological impacts cardiac myocytes, neurons, epithelial cells, and smooth
muscle cells. Cyclic adenosine monophosphate (cAMP), a well-known intracellular
secondary messenger, can activate numerous downstream effector proteins, generating
downstream signaling pathways that regulate many functions in cells. A role for
cAMP in ion channel regulation has been established, and recent findings show that
cAMP signaling plays a role in Kv7 channel regulation. Although cAMP signaling is
recognized to regulate Kv7 channels, the precise molecular mechanism behind the
cAMP-dependent regulation of Kv7 channels is complex. This review will summarize
recent research findings that support the mechanisms of cAMP-dependent regulation
of Kv7 channels.
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cAMP-DEPENDENT SIGNALING
Regulators of cAMP: G Protein-Coupled Receptors
First discovered by Dr. Earl W. Sutherland in 1958 (Rall and Sutherland, 1958; Sutherland and Rall,
1958), cyclic adenosine monophosphate (cAMP) is well-recognized as an important intracellular
secondary messenger molecule that can induce a cascade of events to influence cellular function
(Patra and Brady, 2018). cAMP orchestrates numerous signal transduction pathways through the
activation of several downstream effector proteins, resulting in a wide variety of cellular processes
including gene transcription, cell growth and cell differentiation (Dumont et al., 1989; Sassone-
Corsi, 1995; Mayr and Montminy, 2001; Sands and Palmer, 2008; Bacallao and Monje, 2015).
cAMP is created from ATP through the action of Adenylate cyclases (AC), of which there are
nine membrane-bound isoforms (AC 1-9) and one soluble isoform (sASC). The characteristics of
each isoform are summarized effectively in several reviews (Taussig and Gilman, 1995; Simonds,
1999; Hanoune and Defer, 2001; Sadana and Dessauer, 2009; Tresguerres et al., 2011; Halls
and Cooper, 2017). Membrane-bound ACs are stimulated downstream of Gs-specific G protein-
coupled receptor (GPCR) activation, while the sAC is insensitive to GPCR-dependent regulation
(Braun and Dods, 1975; Braun et al., 1977; Forte et al., 1983). When a GPCR is activated by
its extracellular ligand, it causes a conformational change in the receptor which activates the
associated heteromeric G protein complex, consisting of an α, ß and γ subunit. Subsequently,
the Gsα dissociates from the receptor and Gßγ subunits, activating AC and increasing cAMP
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levels (see Pierce et al., 2002 for a detailed review of this signaling
pathway). ACs can also be regulated by other intracellular signals,
including Ca2+ and PKC (see Halls and Cooper, 2017 for a
detailed review).
Phosphodiesterase’s (PDEs) remain the only known route
of cAMP degradation. The expression and localization of
PDEs within a cell controls the magnitude and duration of
cAMP-dependent events, as well as the compartmentalization
and intracellular gradients of cAMP (Baillie, 2009). Thus, the
expression and localization of PDEs in a cell contributes to the
specificity of the cAMP-response following activation.
Effectors of cAMP: PKA and EPAC
cAMP mediates its effect by activation of effector proteins
including protein kinase A (PKA), Epac (Exchange protein
directly activated by cAMP), or cyclic nucleotide-gated channels
(CNGCs) (Shabb, 2001; Bos, 2006; Biel and Michalakis, 2009).
For many years it was believed that the effects of cAMP
were mediated exclusively through the activation of intracellular
PKA. PKA is a heterotetrameric holoenzyme consisting of
two regulatory (R) subunits and two catalytic (C) subunits
(Krebs and Beavo, 1979; Taylor et al., 2013; Turnham and
Scott, 2016). There are two types of regulatory subunits,
RI and RII, each consisting of two isoforms, RIα, RIβ,
RIIα, RIIβ, each having different tissue expression, subcellular
localization and cAMP binding affinity (Bechtel et al., 1977;
Corbin et al., 1977, 1978; Zoller et al., 1979; Rannels and
Corbin, 1980; Ringheim and Taylor, 1990; Taylor et al., 2012;
Weigand et al., 2017). PKA that contains either RI or RII,
form the two classes of PKA termed type I or type II,
respectively. Binding of four cAMP molecules to each R
subunit induces a conformational change and activates the
kinase, resulting in the free catalytic subunits phosphorylating
serine and threonine residues in specific substrate proteins
(Welch et al., 2010).
Scaffolding proteins, such as A Kinase Anchoring Proteins
(AKAPs; reviewed in Rubin, 1994; Scott et al., 2013; Dema et al.,
2015) bind to the PKA-R subunits at the dimerization/docking
domain at the N-terminus and targets PKA to specific
subcellular locations to ensure specificity in signal transduction
by placing PKA close to its appropriate substrate target, allowing
compartmentalization of PKA (Scott et al., 1990; Carr et al.,
1991; Bauman et al., 2006; Gold et al., 2006). AKAPs also bind
other proteins such as protein kinase C and PDEs (Moleschi and
Melacini, 2014). The AKAP family has more than 50 members
and can be classified according to their binding specificity for
the PKA-R subunits (Wong and Scott, 2004). The majority of the
AKAPs bind to PKA-RII, however, several AKAPs bind to PKA-
RI (Kinderman et al., 2006; Sarma et al., 2010). Only a few AKAPs
have dual-specificity and can bind to both PKA-RI and PKA-RII,
although with lower affinity for PKA-RI (Burns et al., 2003). This
lower affinity for PKA-RI is due to the structural difference in the
dimerization/docking domain in the N-terminal of RI (Huang
et al., 1997; Gold et al., 2006). AKAPs are expressed in different
tissues of the body and can facilitate tissue-specific signaling in
many cells types including neurons (Glantz et al., 1992; Moita
et al., 2002; Dell’Acqua et al., 2006), heart (Fink et al., 2001; Marx
et al., 2002; Ruehr et al., 2004), and pancreas (Lester et al., 1997).
cAMP also activates Epac (Exchange protein directly activated
by cAMP) (de Rooij et al., 1998; Kawasaki et al., 1998).
Epac proteins, stimulated by cAMP binding, activate the Ras
superfamily of small GTPases, Rap1 and Rap2. There are two
known Epac proteins, Epac1 and Epac2, which are both present
in almost all tissues but have different expression levels (Roscioni
et al., 2008). Epac acts as guanine-nucleotide exchange factors
and catalyzes the exchange of GDP for GTP on Rap1 and
Rap2 with subsequent activation of these two GTPases (Cheng
et al., 2008). This leads to activation of further downstream
pathways, which will result in a variety of cellular functions,
depending on specific tissue and cell type. In cardiac myocytes,
for example, Epac plays a role in the cardiac Ca2+ regulation by
increasing Ca2+ release from the sarcoplasmic reticulum (SR) via
ryanodine receptor 2 (RyR2) and thereby effecting contraction
(Fujita et al., 2017). Furthermore, a signaling pathway in which
cAMP acts via Epac to modulate ion channel function has
been identified (Renström et al., 1997; Kang et al., 2006; Stott
et al., 2016). Additionally, Epac enhances the synaptic release
of neurotransmitters following cAMP elevation in neurons
(Shariati et al., 2016).
Cyclic nucleotide-gated channels (CNGCs) are also activated
directly by cAMP signaling (Ludwig et al., 1998; Santoro et al.,
1998). CNGCs are non-selective cation channels expressed in
many tissues, including the heart, lung, kidney, pancreas, liver,
spleen, testis and various neuronal systems (Kaupp and Seifert,
2002; Biel and Michalakis, 2007; Biel, 2009). CNGCs are activated
by direct binding of cAMP or cGMP to the channel and activation
of the channel results in the influx of extracellular cations causing
depolarization of the cell membrane. One example of a CNGC
is the hyperpolarization-activated and cyclic nucleotide–gated
channels (HCN), which are expressed in the heart and the
nervous system. These channels mainly conduct Na+ and K+ and
are activated by a hyperpolarized membrane potential and
stimulated by intracellular cyclic nucleotides. HCN channels are
responsible for the “funny current” (If) in the heart and neurons,
where they regulate pacemaker activity and neuronal firing
(Difrancesco, 1986; DiFrancesco and Tortora, 1991; Moosmang
et al., 1999; DiFrancesco, 2020).
KCNQ-ENCODED POTASSIUM
CHANNELS
There are 12 sub-families of voltage-gated potassium channels
(Kv1-Kv12), within which the Kv7 potassium channel family
consists of five isoforms encoded by the KCNQ1-5 genes
(Kv7.1-Kv7.5) (Robbins, 2001; Gutman et al., 2005). Like all
Kv channels, Kv7 channels are voltage-sensing channels and
open and close upon changes in transmembrane potential to
selectively let K+ ions pass through the channel. The Kv7
channels are comprised of four α-subunits, with each α-subunit
consisting of six transmembrane (TM) spanning domains (S1-
S6). S1-S4 form the voltage-sensing domain, while S5-S6 form
the pore domain. Each α-subunit contains cytoplasmic amino
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(N) – and carboxyl (C) – termini, which are essential for
channel tetramerization and channel regulation (Barros et al.,
2012). In the C-terminus of the channel, a coiled-coil sequence
motif is the major determinant of channel assembly (Jenke
et al., 2003; Schwake et al., 2003, 2006). Assembly of all
four α-subunits placed in a cylindrical arrangement creates
a pore through which the K+ ions are conducted selectively
(Heginbotham et al., 1992; Doyle et al., 1998). This assembly
can be done with four identical α-subunits from the same
Kv7 isoform to form homomeric channels, or by combining
at least two types of α-subunits with other Kv7 isoforms to
form heteromeric channels. Kv7.1 was thought to only form
as a homotetrameric channel (Schwake et al., 2000); however,
heterotetrameric assembly with Kv7.5 has been suggested
(Oliveras et al., 2014). Kv7.3 homomers are weakly effective but
form functional heterotetramers with Kv7.2 (Schroeder et al.,
1998; Wang et al., 1998), Kv7.4 (Kubisch et al., 1999) and Kv7.5
(Schroeder et al., 2000a) subunits, and Kv7.4 heterotetramizes
with Kv7.5 (Bal et al., 2008; Brueggemann et al., 2014b; Chadha
et al., 2014; Jepps et al., 2015). Kv7 channels also interact
with KCNE-encoded single transmembrane-spanning auxiliary
protein subunits [KCNE1-5; also called MinK and MinK-related
peptides (MiRPs)] that function as β or ancillary subunits (Abbott
and Goldstein, 1998; McCrossan and Abbott, 2004; Abbott, 2016;
Jepps, 2017). These KCNE proteins cannot form functional
channels themselves but coassemble with Kv7 channels to
modulate several functional properties of the channel, including
membrane trafficking, voltage dependence, and kinetics of
channel opening and closing (McCrossan and Abbott, 2004;
Kanda and Abbott, 2012). Finally, Kv7 channels have a large
cytoplasmic C-terminal composed of four segments (helix A-D)
(Haitin and Attali, 2008; Xu et al., 2013; Barrese et al., 2018).
In addition to coordinating channel tetramerization, several
regulatory molecules interact with the C-terminal region to
modulate Kv7 channel function, including calmodulin (CaM),
phosphatidylinositol 4,5-biphosphate (PIP2), protein kinase C
(PKC), protein kinase A (PKA), A-kinase-anchoring protein
(AKAP), ankyrin G (Ank-G) and Nedd4-2 (summarized by
Haitin and Attali (2008) and Barrese et al., 2018).
This review will now focus on the mechanisms of cAMP-
dependent regulation of Kv7 channels and explore a possible
role for this mechanism for therapeutic targeting in diseases
associated with Kv7 channel dysfunction.
cAMP REGULATION of Kv7 CHANNELS
Kv7.1
Kv7.1 channels are expressed in several tissues throughout the
body including the heart, uterus, and epithelial cells of the
inner ear, pancreas, airways, gastrointestinal tract and kidneys.
In the heart, Kv7.1 associates with the ancillary subunit KCNE1
to constitute the channel responsible for the late repolarizing
current termed IKs (Barhanin et al., 1996; Sanguinetti et al.,
1996). Kv7.1 also associates with KCNE1 in the inner ear,
where they regulate auditory function and pancreatic acinar
cells where activation of the Kv7.1-KCNE1 channel provides the
driving force for Cl− secretion (Kim and Greger, 1999; Köttgen
et al., 1999; Warth et al., 2002). In addition, Kv7.1 channels
in the pancreatic ß-cells contribute to the regulation of insulin
secretion, and loss of function mutations in the KCNQ1 gene
leads to impaired ß-cell insulin secretion, which is associated with
type 2 diabetes (Ullrich et al., 2005; Unoki et al., 2008; Yasuda
et al., 2008; Yamagata et al., 2011; Liu et al., 2014; Torekov et al.,
2014; Min Lee et al., 2017; Zhang et al., 2020). Furthermore,
association of Kv7.1 with KCNE3 in epithelial tissues of the
colon, small intestine and airways regulates the transport of water
and salts (Schroeder et al., 2000b; Grahammer et al., 2001a,b;
Vallon et al., 2005).
Kv7.1-KCNE1 channels have been studied extensively in
cardiac myocytes where the channel is important for delayed
cardiac repolarization and shapes action potential duration
(Terrenoire et al., 2005). In addition, it is enhanced by
sympathetic nerve activity through activation of β-adrenergic
receptors (Bennett and Begenisch, 1987; Yazawa and Kameyama,
1990). Stimulation of the β-adrenergic receptor by noradrenaline
released from the cardio-accelerator nerve causes an elevation
of cAMP that increases IKs via PKA-dependent phosphorylation
(Yazawa and Kameyama, 1990).
As mentioned previously, PKA actions are regulated by
AKAPs, by positioning PKA and other cAMP-responsive
enzymes in proximity to their substrates. In the heart,
several AKAPs are expressed, including AKAP79/150 (human
AKAP79/murine AKAP150), AKAP15/18δ and AKAP9. AKAP9,
better known as yotiao, facilitates PKA-phosphorylation of serine
27 in the Kv7.1 N-terminus required for the proper functioning
of the channel (Walsh et al., 1988; Walsh and Kass, 1991;
Potet et al., 2001; Marx et al., 2002). Yotiao also associates
with protein phosphatase 1 (PP1), phosphodiesterase (PDE) and
AC to control IKs phosphorylation status (Terrenoire et al.,
2009; Li et al., 2012). Yotiao binds directly to Kv7.1 C-terminus
via a leucine zipper motif, an amino acid sequence in the C
terminus of Kv7.1, and disruption of the complex by mutations
in yotiao or KCNQ1 are associated with Long QT Syndrome
(Kass et al., 2003; Fodstad et al., 2004; Chen et al., 2007).
Besides acting as a scaffold protein, yotiao has a functional
role that occurs after IKs phosphorylation. Studies revealed
that cAMP-dependent activation of Kv7.1-KCNE1 depends not
only on serine 27 phosphorylation but also requires the direct
binding of yotiao to the Kv7.1 at the leucine zipper motif
(Kurokawa et al., 2004; Chen et al., 2005; Chen and Kass, 2006).
Furthermore, it was revealed that yotiao itself is a substrate
for PKA phosphorylation and can be phosphorylated upon β
adrenoceptor stimulation (Chen et al., 2005). Serine 43 was
identified as target residue for PKA phosphorylation on yotiao,
with mutations of this residue dampening cAMP effects on the
IKs current, even though yotiao binding and phosphorylation of
Kv7.1 channels were not affected. Taken together, these studies
conclude that AKAP protein yotiao has a crucial and complex
regulatory role on the cAMP-dependent activity of IKs channels
(see Figure 1A).
Although PKA activation of Kv7.1 following β adrenergic
stimulation can increase IKs, chronic β adrenergic stimulation
downregulates the IKs response (Mona et al., 2014). Chronic
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FIGURE 1 | Schematics of known cAMP-dependent Kv7 channel regulation in panel cardiac (A), neurones (B) and smooth muscle cells (C). The figure summarizes
many of the known interaction partners involved in the cAMP-mediated regulation of Kv7 channels in the different cells types, thereby highlighting the heterogeneity
of cAMP-Kv7 channel signaling. It should be noted that, although AKAP79/150 is associated with Kv7.2 channels, it has not been included in the figure since there is
no evidence of its involvement in PKA phosphorylation of the channel.
β adrenergic stimulation led to a significant decrease in
KCNE1 but not KCNQ1 mRNA expression in guinea pig
cardiomyocytes. Furthermore, chronic in vitro and in vivo
isoprenaline stimulation reduced KCNE1 protein expression and
KCNE1 membrane expression in guinea pig cardiomyocytes.
This effect was mediated via Epac1 and not PKA activation,
leading to increased translocation of nuclear factor of activated T
cell (NFAT), which was responsible for KCNE1 downregulation
(Mona et al., 2014).
In the inner ear, cAMP activates Kv7.1-KCNE1 channels,
which results in the secretion of K+, necessary for normal
hearing (Wang et al., 1996; Neyroud et al., 1997). However,
the precise mechanisms underlying the cAMP-regulated increase
in K+ conductance in the inner ear are unclear (Sunose
et al., 1997). In the intestine, cAMP enhances Kv7.1-KCNE3
currents and stimulates Cl− secretion by hyperpolarizing the
cell membrane and thereby amplifying the driving force for
Cl− exit through cystic fibrosis transmembrane conductance
regulator Cl− channels (Lohrmann et al., 1995; Diener et al.,
1996; Suessbrich et al., 1996; Devor et al., 1997; Rufo et al., 1997;
Schroeder et al., 2000b; Bajwa et al., 2007). An essential role
for KCNE3 in cAMP-driven Cl− secretion has been suggested
from the observation that KCNE3 knockdown reduced cAMP-
mediated Cl− secretion across tracheal and intestinal epithelia
without altering Kv7.1 expression (Preston et al., 2010) but the
precise mechanism by which cAMP stimulates Kv7.1-KCNE3
channels in these cells is still unknown. Like for intestine
epithelial cells, airway epithelial cells secrete Cl− stimulated by
the cAMP-signaling pathway, where blockade of Kv7.1 channels
suppress the cAMP-mediated Cl− secretion (Mall et al., 2000;
Grahammer et al., 2001b; MacVinish et al., 2001; Cowley and
Linsdell, 2002; Kim et al., 2007). However, the direct mechanism
how cAMP mediates Kv7.1 channel activation responsible for
Cl− secretion needs to be further investigated. In pancreatic
β-cells, Kv7.1 channels contribute to insulin secretion. Besides,
a link between cAMP and insulin secretion has established
(Malaisse and Malaisse-Lagae, 1984; Seino and Shibasaki, 2005).
However, it remains to be determined if Kv7.1 channels play a
role in this cAMP-dependent mechanism.
Modifiers of cAMP-Mediated Regulation
of Kv7.1 Channels
Although the direct regulation of cAMP signaling on Kv7.1
channel activity is well described, several factors can modulate
this interaction indirectly. For instance, Nicolas et al. (2008)
determined that the PKA-dependent regulation of IKs was
microtubule-dependent (Nicolas et al., 2008). Cytoskeletal
microtubules are essential for proper trafficking of cardiac ion
channels to the plasma membrane (Steele and Fedida, 2014),
and although a physical interaction between Kv7.1 and the
microtubule forming protein, β-tubulin, was shown, disruption
of the microtubules did not modify the Kv7.1-KCNE1 channel
membrane density or baseline currents in transfected COS-7 cells
or cardiomyocytes. However, microtubule disruption decreased
the IKs response to PKA-mediated stimulation. This was not
due to altered channel phosphorylation, yotiao phosphorylation
or the interaction between both proteins, suggesting that
microtubules play an important role in the coupling of PKA-
dependent Kv7.1 phosphorylation and its channel activation
(Nicolas et al., 2008).
The effect of cAMP on the trafficking of Kv7.1 channels
has also been investigated. PKA inhibition in Madin-Darby
canine kidney (MDCK) cells reduces Kv7.1 channel membrane
expression and increases intracellular accumulation of the Kv7.1
protein in late endosomes/lysosomes (Andersen et al., 2015). This
suggests a role for PKA-mediated trafficking of Kv7.1 channels,
although this was not a result of channel phosphorylation.
A previous study by the same group found that two cAMP
phosphorylation residues on Kv7.1, serine 27 and serine 92, were
not crucial for trafficking Kv7.1 (Lundby et al., 2013). Instead the
E3 ubiquitin ligase Nedd4-2 is required in this PKA-dependent
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trafficking pathway (Andersen et al., 2015). Nedd4-2 is an
ubiquitin-protein ligase that binds to ion channels containing
a C-terminal proline-rich segment (PY motif) (Manning and
Kumar, 2018). Among the Kv7 channels, Kv7.1 is the only
isoform containing this sequence motif. Binding of Nedd4-2
to the C-terminal PY motif in Kv7.1 channels regulates the
ubiquitylation of the channel and its internalization (Jespersen
et al., 2007). Andersen et al. (2015) concluded that PKA
regulated Nedd4-2-dependent trafficking of Kv7.1 but the precise
mechanism how PKA influences Nedd4-2 needs to be determined
(Andersen et al., 2015).
Kv7.2 and Kv7.3
Kv7.2 and Kv7.3 channels are widely expressed in neuronal
tissues, where they form a heteromeric channel that generates
the “M-current” (Brown and Adams, 1980; Wang et al., 1998;
Wickenden et al., 2001; Roche et al., 2002; Shah et al., 2002). Kv7.5
channels are also a component of the M-channel in heteromeric
formation with Kv7.3 (Lerche et al., 2000; Schroeder et al., 2000a;
Tzingounis et al., 2010). The M-current in neurons maintains
the negative resting membrane potential to limit neuronal
firing and excitability (Marrion, 1997; Jentsch, 2000). M-currents
are inhibited by Gq/11 coupled GPCRs such as muscarinic
acetylcholine receptors M1, M3 and M5, or bradykinin B2
receptors. Stimulation of these receptors decreases M-current
density resulting in depolarization, which subsequently increases
neuronal excitability (Brown and Selyanko, 1985; Cruzblanca
et al., 1998). It is well established that disruption of the M-current
due to mutations in either KCNQ2 or KCNQ3 genes causes
excessive neuronal excitability, leading to neuronal diseases,
such as benign familial neonatal convulsions and epileptic
encephalopathy (Biervert et al., 1998; Charlier et al., 1998; Singh
et al., 1998; Jentsch, 2000; Castaldo et al., 2002; Borgatti et al.,
2004; Weckhuysen et al., 2012, 2013).
Kv7.2/Kv7.3 currents in overexpressed Xenopus oocytes
are enhanced by cAMP, which relies on PKA-mediated
phosphorylation of serine 52 in the Kv7.2 N-terminus (Schroeder
et al., 1998). Furthermore, Cooper et al. (2000) identified an
interaction of Kv7.2 and PKA subunits in human brain samples
by co-immunoprecipitation and affinity chromatography
(Cooper et al., 2000). In addition, AKAP79/150 is associated with
Kv7.2 channels (Hoshi et al., 2003, 2005; Zhang and Shapiro,
2012). Although the core AKAP79/150 complex contains PKA
(Gold et al., 2006), it has not yet been determined whether
AKAP70/150 facilitates PKA phosphorylation of Kv7.2 channel;
however, AKAP79/150 is essential for the recruitment and
phosphorylation of Kv7.2 channels by PKC (Hoshi et al., 2003;
Higashida et al., 2005; Zhang and Shapiro, 2012).
Multiple other phosphorylation sites of Kv7.2/Kv7.3 channels
have been identified using mass spectrometry. However, the
responsible kinase for this phosphorylation remains elusive as
not only PKA but also PKC and src tyrosine kinase can regulate
Kv7.2/Kv7.3 channel phosphorylation (Gamper et al., 2003; Hoshi
et al., 2003; Li et al., 2004; Surti et al., 2005). A recent study by
Salzer et al. (2017) found 13 phosphorylation sites for human
Kv7.2 using mass spectrometry, one already identified (serine 52)
located at the N-terminus, whereas the remaining 12 were located
in the C-terminus. Using in vitro phosphorylation assays the
authors identified the protein kinases responsible for C-terminus
Kv7.2 phosphorylation. Only two of the 12 residues (serine 438
and serine 455) were phosphorylated by PKA. Inhibition of
PKA reduced Kv7.2 phosphorylation, which decreased channel
sensitivity to PIP2 depletion, thereby attenuating Kv7 channel
regulation via M1 muscarinic receptors. Thus, phosphorylation
of the Kv7.2 channel is necessary to maintain a reduced affinity
for PIP2 (Salzer et al., 2017; Figure 1B).
Kv7.5 channels are expressed in some regions of the brain,
where they coassemble with Kv7.3 channels. Kv7.5/Kv7.3
channels show similar currents to the Kv7.2/Kv7.3 currents and
are also inhibited by M1 muscarinic receptor activation
(Schroeder et al., 2000a). Kv7.5 can be phosphorylated
and stimulated by PKA on serine 53 on the N-terminus
(Brueggemann et al., 2018); however, it is still unclear whether
the heterotetrameric Kv7.3/Kv7.5 channel found in neurones are
regulated in the same way by cAMP.
Kv7.4 and Kv7.5
Kv7.4 channels are expressed in the inner ear and auditory
nerves (Kharkovets et al., 2000), the substantia nigra (Hansen
et al., 2008), skeletal muscle cells (Iannotti et al., 2010), the
mitochondria of cardiac myocytes (Testai et al., 2016) and in
smooth muscle cells extensively (see Barrese et al., 2018 for a
recent review of the smooth muscle literature). Kv7.5 channels
are expressed in the brain, where they play a role in the regulation
of neuronal excitability, and in skeletal and smooth muscle
(Schroeder et al., 2000a; Roura-Ferrer et al., 2008; Iannotti et al.,
2010; Haick and Byron, 2016).
In smooth muscle, there is evidence Kv7.4 and Kv7.5 channels
exist as both homomers and heteromers (Brueggemann et al.,
2011, 2014b; Chadha et al., 2014; Jepps et al., 2015). The first
indication that smooth muscle Kv7 channels were activated by
cAMP came from gastric smooth muscle cells. In these cells, β
adrenoceptor stimulation with isoprenaline induced a current
that resembled the neuronal M current, although at this time the
molecular identity of the M current was still unknown (Sims et al.,
1988).
In vascular smooth muscle, the use of pharmacological
inhibitors and molecular interference has identified a role for Kv7
channels in receptor-mediated relaxations. The first identification
was for β adrenoceptor-mediated vasodilatation in the renal
vasculature (Chadha et al., 2012). Inhibition of Kv7 channels by
XE991 or linopirdine and knockdown of Kv7.4 with KCNQ4-
targeted small interfering RNA (siRNA), attenuated arterial
relaxations to the β adrenoceptor agonist, isoprenaline (Chadha
et al., 2012). More recent, experiments with morpholino-
mediated suppression of Kv7.4 translation corroborated these
findings (Stott et al., 2018). Furthermore, isoprenaline increased
Kv7 currents in vascular smooth muscle cells isolated from
rat arteries and in A7r5 cells (a rat aortic smooth muscle cell
line) (Chadha et al., 2012; Stott et al., 2015; Mani et al., 2016;
Brueggemann et al., 2018).
In hypertension, Kv7.4 protein expression is diminished
causing reduced hyperpolarization and relaxation of the smooth
muscle cells. Furthermore, in renal arteries from spontaneously
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hypertensive rats, where Kv7.4 expression is reduced, receptor-
mediated relaxations were diminished (Jepps et al., 2011;
Chadha et al., 2012). Interestingly, in the cerebral arteries
from hypertensive rats, there is no compromise of Kv7.4
channel expression and CGRP receptor-mediated relaxations are
unaffected (Chadha et al., 2014).
Although targeting Kv7.4 in isolated vessels with siRNA-
and morpholino-induced knockdown inhibits isoprenaline- and
CGRP-induced relaxations (Chadha et al., 2014; Stott et al.,
2018), there is evidence that Kv7.5 is required to elicit
cAMP-dependent relaxations. In A7r5 cells, stimulation of β
adrenoceptors and the downstream pathway enhanced the
currents produced by Kv7.5 channels and heterotetrameric
Kv7.4/Kv7.5 channels expressed exogenously, but not when
homomeric Kv7.4 channels were expressed (Mani et al., 2016),
suggesting cAMP-mediated regulation of Kv7.4 and Kv7.5
depends on the stoichiometry of the channel.
The precise Kv7 channel stoichiometry eliciting cAMP-
dependent relaxations in vascular smooth muscle is still
unknown. Kv7.4 channels are important for proper Kv7 channel
function in arteries, highlighted by their downregulation in
arteries from hypertensive animals, whereas both Kv7.4 and Kv7.5
may play a role in the cAMP-dependent activation. To further
complicate this mechanism, KCNE4 co-assembles with Kv7.4 and
Kv7.5 in vascular smooth muscle cells to alter the biophysical
properties and cellular localization of these channels. Targeted
knockdown of Kcne4 in rat arteries depolarized the smooth
muscle resting membrane potential and reduced vasorelaxations
to Kv7 channel activators. Interestingly, in Kcne4 knockout mice,
only the males displayed attenuated Kv7 channel function, but
both male and female Kcne4 knockout mice had attenuated
responses to isoprenaline. Given that Kcne4 expression has been
shown in several arterial beds, it could be facilitating the Kv7
channel-dependent cAMP relaxations (Jepps et al., 2015; Abbott
and Jepps, 2016). The expression of KCNE4 in A7r5 cells is
yet to be determined but including KCNE4 subunits in future
studies investigating the cAMP-dependent Kv7.4/Kv7.5 channel
activation could give valuable insight into this mechanism.
Both PKA and Epac enhance Kv7 channel activity in vascular
smooth muscle (Khanamiri et al., 2013; Mani et al., 2016; Stott
et al., 2016). Isoprenaline-mediated relaxations were attenuated
by PKA inhibition in renal arteries, whilst the isoprenaline
relaxations in mesenteric arteries were not affected (Stott
et al., 2016). In the mesenteric artery, isoprenaline-induced
linopirdine-sensitive relaxations were elicited through activation
of Epac, which is present in both rat renal and mesenteric
arteries, but more predominant in mesenteric arteries. With
electrophysiology experiments, Kv7 currents were increased with
direct Epac stimulation in smooth muscle cells isolated from
renal and mesenteric arteries (Stott et al., 2016). These data
highlight that cAMP-dependent stimulation of Kv7 channels in
vascular smooth muscle is not only dependent on the Kv7 channel
architecture but also the channel’s association with downstream
cAMP effector proteins, all of which are likely to be artery specific
(see Figure 1C).
Kv7 channels are also expressed in airway smooth muscle cells
(ASMCs) of rodents and humans. Pharmacological activators
of Kv7 channels, including retigabine, flupirtine and S-1, relax
airway smooth muscle cells from guinea pigs and human, and
are important regulators of airway diameter (Brueggemann
et al., 2012; Evseev et al., 2013). β2-adrenergic receptor agonists
are commonly used for the treatment of asthma to relieve
hyperconstriction of the airway (Cazzola et al., 2013), and
are able to enhance Kv7 currents in ASMCs thereby inducing
relaxation of rat airways (Brueggemann et al., 2014a). A later
study by Brueggemann et al. (2018) revealed that β adrenoceptor
stimulation activated the Kv7.5 channels in cultured human
ASMCs, a response which was mediated by the PKA pathway
(Brueggemann et al., 2018). This study identified serine 53
on the Kv7.5 N-terminus to be responsible for the increased
Kv7.5 currents in response to cAMP elevation, which could be
a common mechanism for β adrenoceptor/cAMP activation of
Kv7.5 channels in vascular smooth muscle cells. Recent findings
show that phosphorylation of serine 53 on the N-terminus of
Kv7.5 increases its affinity for PIP2, corresponding to enhanced
channel activation (Brueggemann et al., 2020).
Kv7.4 and Kv7.5 are also expressed in the smooth muscle of
the gastrointestinal tract (Ohya et al., 2002; Jepps et al., 2009;
Ipavec et al., 2011; Adduci et al., 2013), bladder (Streng et al.,
2004; Rode et al., 2010; Svalø et al., 2012, 2013; Afeli et al.,
2013; Anderson et al., 2013), penis (Jepps et al., 2016) and
uterus (McCallum et al., 2009) where important functional roles
have been established. Whether Kv7 channels in these tissues
are subjected to the same cAMP-dependent regulation as in
vascular and airway smooth muscle remains to be determined.
Given that, even within the vasculature, there are differences
in the cAMP-dependent mechanisms that lead to Kv7 channel
stimulation, the Kv7 channels in these smooth muscle tissues
cannot be assumed to behave in the same way as has been
described in airway and vascular smooth muscle. Future work
should investigate how Kv7 channels are subjected to cAMP-
dependent regulation in these tissues, which could lead to
novel therapeutic strategies for the treatment of various smooth
muscle disorders, such as constipation, preeclampsia, erectile
dysfunction and incontinence.
Modifiers of cAMP-Mediated Regulation
of Kv7.4 Channels
Gβγ subunits have a regulatory role on the modulation of
Kv7.4 channels in vascular smooth muscle cells, which is Gβ
subunit-specific (Stott et al., 2015, 2018; Greenwood and Stott,
2020). Gβγ subunit binding to Kv7.4 channels enhances the
current in both HEK and CHO cells expressing Kv7.4, and in
rat renal arterial smooth muscle cells. In addition, Gβγ subunit
interaction is critical for the β adrenergic dependent activation
of Kv7 channels in rat renal arteries, but not in rat mesenteric
arteries. Contrarily, inhibition of Gβγ subunits attenuated
the CGRP dependent relaxations in mesenteric arteries, but
showed no effect on CGRP relaxation in cerebral arteries,
highlighting the role of Gβγ in Kv7-dependent vasorelaxations
to be artery specific and dependent on the vasorelaxant
(Stott et al., 2018).
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The microtubule network has also been implicated in the
Kv7 channel-dependent cAMP-mediated relaxations in rat
mesenteric and renal arteries (Lindman et al., 2018). Disruption
of the microtubule network with colchicine increased the
membrane expression of Kv7.4 channels, which enhanced
membrane hyperpolarization, decreases in intracellular Ca2+
and vasorelaxation to isoprenaline and forskolin in a Kv7
channel-dependent manner, specifically (Lindman et al.,
2018). Further work in this area is required to determine
whether the microtubule network regulates cAMP signaling in
smooth muscle cells.
CONCLUSION
The second messenger cAMP regulates Kv7 channel activity in
many cell types, including cardiac myocytes, smooth muscle and
neurons. However, cAMP-mediated regulation of Kv7 channels is
complex and many aspects remain to be elucidated. Generation
of cAMP results from stimulation of AC, of which 9 isoforms
exist. Depending on the isoforms expressed in a cell type,
extracellular signals through GPCR activation can be integrated
differently. Identifying how different AC isoforms contribute to
cAMP-dependent activation of Kv7 channels in different tissue
types could lead to targeting of a particular isoform providing
therapeutic benefits with fewer adverse effects. Furthermore, the
recent discovery of Epac activation of Kv7.4/Kv7.5 channels in
vascular smooth muscle adds more complexity to this pathway.
Determining whether this cAMP/Epac pathway plays a role
in the activation of other Kv7 channels will be necessary to
fully understand the physiological impact of cAMP signaling
through Kv7 channels. Finally, the importance of the KCNE
subunits in the cAMP-dependent regulation of Kv7 channels
has often been overlooked but is likely to have a substantial
role. By better defining the cAMP regulation of Kv7 channels in
different tissues, it may become possible to exploit subtle tissue-
specific differences in the activation pathways in order to generate
novel therapeutics.
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